Tech Transfer Central

The Status of VC and Angel Funding for University Start-ups During the Pandemic: Overcoming Current Challenges and Preparing for the Future

Format: On-Demand Video/Transcript, or DVD
Originally presented: October 15, 2020

Share:
Twitter Facebook Linkedin Pinterest Email
Price: $197
order button view cart

In the COVID-19 era, VC and angel funding for university start-ups is more of a challenge than ever for most ventures. For some, however, the technology needs associated with the pandemic have actually increased investor interest. Telehealth and other COVID-related businesses are prime examples of potential unicorns for investors, yet many university-based start-ups have been stalled to clear the way for emergency projects. Others lack leadership and business mentors, making them riskier investments. At the same time, there’s plenty of money on the sidelines, but will it be deployed – and when, and to what sectors? 

In all the uncertainty surrounding the pandemic and the struggling economy, the bottom line is it’s hard to know where you stand, what the prospects are for funding, and how to proceed with your university’s start-up plans.

This webinar will cut through the confusion to provide you with supporting data and guidance on what to expect from angel and venture capital investors now and in the coming months as conditions change.

Tech Transfer Central’s Distance Learning Division has teamed up with Bryn Rees, Assistant Vice Chancellor of Research & Innovation and Managing Director of Venture Partners for the University of Colorado Boulder, and Kirsten Leute, Partner in charge of University Relations with Osage University Partners (OUP), to bring you this critical webinar:

Register today to participate in this expert-led discussion, and gain important insights into how you can shake loose investment dollars for your promising new ventures and prepare them for long-term success.

Here’s a quick look at what these two university start-up veterans will cover:

  • 2020 data on how university start-ups are faring
  • Observations and lessons learned by individual university start-ups that are raising capital during the pandemic
  • The latest trends in start-up capital, and how it can inform your strategy
  • Insights into the ways university start-ups are successfully closing financings in this unprecedented environment

Meet your presenters:

Bryn ReesBryn Rees
Assistant Vice Chancellor, Research & Innovation
Managing Director, Venture Partners
University of Colorado Boulder

Bryn is the Assistant Vice Chancellor for Research & Innovation and Managing Director of Venture Partners at CU Boulder. Venture Partners is the tech transfer function for the university and is also a holistic accelerator for early-stage deep tech innovations, including entrepreneur education and development, mentorship, and seed funding. Bryn has been with Venture Partners at CU Boulder since 2009 and was formerly Senior Officer with the technology transfer group at the University of British Columbia. He began his career in research innovation at GlaxoSmithKline, where he managed clinical research in pharmacogenetics and genetic studies of complex diseases. He holds an undergraduate degree in biochemistry from the University of Victoria, a master’s in biotechnology from the University of Toronto, and a second master’s degree in counseling psychology from Naropa University.

Kirsten LeuteKirsten Leute
Partner, University Relations
Osage University Partners (OUP)

In leading University Relations for OUP, Kirsten is responsible for the relationships with approximately 100 academic institutions that are partnered with the fund, engaging potential new partner institutions, and creating and delivering value-add programs for the partnered academic institutions. Kirsten is an experienced technology transfer professional, having spent 19 years in technology transfer at Stanford University and the German Cancer Research Center. Prior to joining OUP, she was Associate Director at Stanford’s Office of Technology Licensing. Over her career at Stanford, she managed portfolios of inventions in most technology areas, but concentrated in biotechnology.

Kirsten continues to be actively involved in technology transfer and university start-ups outside her daily work. She is currently on advisory boards for the University of Michigan, University of Arizona, and Oregon Health & Sciences University technology transfer offices, is a board member of Women in Bio, is an Adcom member for America’s Seed Fund (NSF’s SBIR/STTR program), and is a former two-time board member for the Association of University Technology Managers.

Quality and Value

We stand 100% behind the quality and value of our products. If you are dissatisfied, simply let us know and we will send you an immediate refund for your entire order -- no questions asked.

order button
view cart


Click here for a printable order form